Interactions between the renin-angiotensin system, nitric oxide and endothelin;Interactions entre le systeme renine-angiotensine, le monoxyde d'azote et l'endotheline

Nephrologie

Volumn 19, Issue 7, 1998, Pages 437-441

  Dussaule, J C ^a   Tharaux, P L ^a   Boffa, J J ^a   Ardaillou, R ^a   Chatziantoniou, C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Angiotensin II; Endothelin; Nitric oxide; Renin

Indexed keywords

ANGIOTENSIN; ENDOTHELIN 1; NITRIC OXIDE; RENIN; ANGIOTENSIN II;

ARTICLE; BLOOD PRESSURE REGULATION; ENDOTHELIUM CELL; FIBROGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SODIUM BALANCE; VASOCONSTRICTION; ANIMAL; HUMAN; PHYSIOLOGY; REVIEW; SECRETION;

ANGIOTENSIN II; ANIMALS; ENDOTHELIN-1; HUMANS; NITRIC OXIDE; RENIN; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTION;

EID: 0031734081     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 1990; 70: 1067-116.
2. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hyper 1992; 20: 113-7.
3. Sigmon DH, Carretero OA, Beierwaltes WH. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; 263: F256-F61
4. Beierwaltes WH, Carretero OA. Non-prostanoid endothelium-derived factors inhibit renin release. Hyper 1992; 19 (Suppl. II): II-68-II-73.
5. Johnson RA, Freeman RH. Renin release in rats during blockade of nitric oxide synthesis. Am J Physiol 1994; 266: R1723-R9.
6. Schricker K, Hamann M, Kurtz A. NO and prostaglandins are involved in the macula densa control of the renin system. Am J Physiol 1995; 269: F825-F30.
7. Gardes J, Poux JM, Gonzalez MF, Alhenc-Gelas F, Menard J. Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney. Life Sci 1992; 50: 987-93.
8. Beierwaltes WH. Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am J Physiol 1995; 269: F134-F9.
9. Greenberg, SG, He XR, Schnermann JB, Briggs JP. Effect of nitric oxide on renin secretion I. Studies in isolated juxtaglomerular granular cells. Am J Physiol 1995; 268: F948-F52.
10. He XR, Greenberg SG, Schnermann JB, Briggs JP. Effect of nitric oxide on renin secretion II. Studies in the perfused juxtaglomerular apparatus. Am J Physiol 1995; 268: F953-F9.
11. Chatziantoniou C, Arendshorst WJ. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol 1993; 265: F853-F62.
12. Chatziantoniou C, Dussaule JC, Arendshorst WJ, Ardaillou R. Angiotensin II receptors and renin release in rat glomerular afferent arterioles. Kidney Int 1994; 46: 1570-3.
13. Chatziantoniou C, Pauti MD, Pinet F, Promeneur D, Dussaule JC, Ardaillou R. Renin release is impaired after nitric oxide inhibition. Kidney Int 1996; 49: 626-33.
14. Tharaux PL, Dussaule JC, Pauti MD, Ardaillou R, Vassitch Y, Chatziantoniou C. Activation of renin synthesis is dependent on intact nitric oxide production. Kidney Int 1997; 50: 626-33.
15. Ritthaler T, Sholz H, Ackermann M, Riegger G, Kurtz A, Krämer B. Effects of endothelins on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 1995; 268: F39-F45.
16. Ritthaler T, Della Bruna R, Krämer B, Kurtz A. Endothelins inhibit cyclic-AMP induced renin gene expression in cultured mouse juxtaglomerular cells. Kidney Int 1996; 50: 108-15.
17. Phelan M, Perrine S, Brauer M, Faller DV. Sickle erythrocytes, after sickling, regulate the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest 1995; 96: 1145-51.
18. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF. Termination of endothelin signaling: Role of nitric oxide. J Cell Physiology 1994; 158: 485-94.
19. Boulanger C, Lüscher T. Release of endothelin from the porcine aorta. J Clin Invest 1990; 85: 587-90.
20. Thompson AC, Valeri R, Lieberthal W. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am. J Physiol 1995; 269: H743-H8.
21. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998; 274: C214-C20.
22. Madrid MI, Garcia-Salom M, Tornel J, de Gasparo M, Fenoy FJ. Interactions between nitric oxide and angiotensin II on renal cortical and papillary blood flow. Hypertension 1997; 30: 1175-82.
23. Thorup C, Kornfeld M, Winaver JM, Goligorsky MS, Moore LC. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Arch 1998; 435: 432-4.
24. Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 1998; 31: 283-8.
25. Zou AP, Wu F, Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 1998; 31: 271-6.
26. Griendling KK, Minieri CA, Ollerenshow JD, Alexendar RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8.
27. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997; 100: 264-9.
28. Takizawa T, Gu M, Chobanian AV, Brecher P. Effect of nitric oxide on DNA replication induced by angiotensin II in rat cardiac fibroblasts. Hypertension 1997; 30: 1035-40.
29. Adachi Y, Hashimoto K, Hisa H, Yoshida M, Suzukikusaba M, Satoh S. Angiotensin II-induced renal responses in anesthetized rabbits: Effects of L-NAME and losartan. Eur J Pharmacol 1996; 308: 165-71.
30. Parekh N, Dobrowolski L, Zou AR, Steinhausen M. Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am J Physiol 1996; 270: R630-R5.
31. Juncos LA, Ren YL, Arima SJ, Garvin J, Carretero OA, Ito S. Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow. Kidney Int 1996; 49: 374-81.
32. Xu Y, Arnal JF, Hinglais N, Appay MD, Laboulandine I, Bariety J, Michel JB. Renal hypertensive angiopathy. Comparison between chronic NO suppression and DOCA-salt intoxication. Am J Hypertension 1995; 8: 167-76.
33. Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol 1995; 38: 269 (Renal Fluid Electrolyte Physiol) Am J Physiol (Renal Fluid Electrolyte Physiol 38) 269: F190-7.
34. Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol 1995; 38: 269 (Renal Fluid Electrolyte Physiol) Am J Physiol (Renal Fluid Electrolyte Physiol 38) 269: F190-7.
35. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-81.
36. Bouriquet N, Dupont M, Herizi A, Mimran A, Casellas D. Preglomerular sudanophilia in L-NAME hypertensive rats : Involvement of endothelin. Hypertension 1996; 27: 382-91.
37. Bou-Gharios G, Garrett LA, Rossert J, Niederreither K, et al. A potent far-upstream enhancer in the mouse proa2(I) collagen gene results in expression of reporter genes in transgenic mice. J Cell Biol 1996; 134: 1333-44.
38. Chatziantoaiou C, Boffa JJ, Dussaule JC, Ardaillou R. Nitric oxide inhibition induces activation of type I collagen gene selectively in renal resistance vessels. J Am Soc Nephrol 1997; 8: A1364.
39. Matsuaka T, Hymes J, Ichikawa I. Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 1996; 7: 2025-43.
40. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, et al. Endothelin-1 transgenic mice develops glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 1997; 99: 1380-9.
41. Moreau P, d'Uscio LV, Shaw S, Takase H, Barton M, Luscher TF. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: Reversal by ET(A)-receptor antagonist. Circulation 1997; 96: 1593-7.
42. Barton M, Shaw S. d'Uscio LV, Moreau P, Luscher TF. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: Role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997; 238: 861-5.
43. Spatz M, Stanimirovic D, Bacic F, Uematsu S, McCarron RM. Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebro microvascular endothelium. Am J Physiol 1994; 266: C654-C60.
44. Sung CR Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther 1994; 271: 429-37.
45. Abernethy DR, Laurie N, Andrawis NS. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance. Clin Pharmacol Ther 1995; 58: 328-34.
46. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, et al. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996; 27: 885-92.
47. Herizi A, Jover B, Bouriquet N, Mimran A. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade. Hypertension 1998; 31: 10-4.
48. Casellas D, Bouriquet N, Herizi A Bosentan prevents preglomerular alterations during angiotensin II hypertension. Hypertension 1997; 30: 1613-20.
49. d'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, Luscher TF. Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 1997; 29: 435-41.
50. Balakrishnan SM, Wang HD, Gopalakrishnan V, Wilson TW, McNeill JR. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 1996; 28: 806-9.
51. Fujisaki H, Ito H, Hirata Y, Tanaka M, et al. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 1995; 96: 1059-65.
52. Jilma B, Krejcy K, Dirnberger E, Eichler HG, Kapiotis S, Dorner GT, Wagner OF. Effects of angiotensin-II infusion at pressor and subpressor doses on endothelin-1 plasma levels in healthy men. Life Sci 1997; 60: 1859-66.